Trademark: 79115776
Word
CARE-FOR-RARE
Status Date
Saturday, May 11, 2024
Registration Number
4366431
Registration Date
Tuesday, July 16, 2013
Filing Date
Thursday, January 5, 2012
Published for Opposition
Tuesday, April 30, 2013
41 Educational services, namely, providing online instruction in the field of science, medicine, healthcare, hygiene and nutrition via an online website, and further training services in the field of science, hygiene, nutrition, healthcare and medicine; providing medical educational services, namely, classes, seminars and webinars in the field of hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome and providing medical information; providing a website featuring non-downloadable electronic publications in the nature of books, magazines and brochures in the field of science, medicine, healthcare, hygiene, nutrition, rare diseases, rare genetically caused diseases, diseases of the blood and the immune system; educational services, namely, providing further education in the field of science via classes, seminars and workshops and organization of educational events in the field of science, medicine, healthcare, hygiene and nutrition; organization of artistic performances and art exhibitions, vernissages and finissages; publication of printed matter in electronic form except for advertising purposes, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children
36 Monetary affairs, namely, financial planning services, accepting and administering monetary charitable contributions; charitable fundraising services, namely, collection of monetary donations for beneficent and charitable purposes; financing of research projects and clinical studies of others; administering monetary charitable contributions for destitute, socially deprived and needy people and families for the purpose of procuring and providing benefits-in-kind, financial advice and consultancy services, namely, for the benefit of people, in particular children, having rare diseases, rare genetically caused diseases, in particular of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel syndrome, and for the benefit of their families and relatives, in particular in emerging and developing countries and administering monetary charitable contributions for students and physicians, pharmacists and natural scientists for further education and training purposes in the field of rare diseases affecting humans
44 Medical services, medical diagnostic services for testing and analysis purposes; out-patient and mobile nursing services, medical and therapeutic care, therapy consultancy for medical purposes, providing and arranging of medical care, in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children; medical testing for diagnostic purposes, namely, clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; psychosocial counseling
42 Scientific and biological research and scientific laboratory services, technological research in the field of medicine, biology, genetics, healthcare, chemistry and biochemistry and technological consulting services in the field of medical diagnosis systems and medical therapeutic systems; clinical and diagnostic research in the field of medicine and genetics, chemical, biological, genetic engineering, molecular biological and biotechnological research; genetic engineering services, conducting of clinical studies for pharmaceutical preparations, research and development services in the field of immunology, gene therapy and stem cell research; conducting scientific investigations for medical purposes; drawing up scientific expert opinions, namely, scientific, medical, clinical therapy and technical surveying; scientific research, biological, chemical and medical research; medical and scientific research featuring the development of new therapies, in particular pharmacotherapy, cell and gene therapy; basic scientific research, therapy development and research services in the field of rare diseases, rare genetically caused diseases, in particular of the blood and immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases affecting humans, in particular children
Color is not claimed as a feature of the mark.
Aug 17, 2012
New Application Office Supplied Data Entered
Aug 16, 2012
Sn Assigned For Sect 66a Appl From Ib
Aug 17, 2012
Assigned To Examiner
Aug 21, 2012
Application Filing Receipt Mailed
Aug 22, 2012
Non-Final Action Written
Aug 23, 2012
Non-Final Action (Ib Refusal) Prepared For Review
Aug 23, 2012
Refusal Processed By Mpu
Feb 6, 2013
Correspondence Received In Law Office
Aug 24, 2012
Non-Final Action Mailed - Refusal Sent To Ib
Sep 15, 2012
Refusal Processed By Ib
Feb 6, 2013
Teas Response To Office Action Received
Feb 11, 2013
Teas/Email Correspondence Entered
Mar 9, 2013
Approved For Pub - Principal Register
Mar 25, 2013
Assigned To Lie
Mar 25, 2013
Law Office Publication Review Completed
Apr 10, 2013
Notice Of Publication
Apr 10, 2013
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Apr 10, 2013
Notification Of Possible Opposition Sent To Ib
Apr 30, 2013
Published For Opposition
Jul 1, 2013
Notification Processed By Ib
Jul 16, 2013
Registered-Principal Register
Oct 16, 2013
Final Disposition Notice Created, To Be Sent To Ib
Dec 13, 2013
Final Disposition Processed
Dec 13, 2013
Final Disposition Notice Sent To Ib
Jan 5, 2014
Final Decision Transaction Processed By Ib
Jun 21, 2018
New Representative At Ib Received
Dec 27, 2018
New Representative At Ib Received
Mar 21, 2019
Teas Section 71 & 15 Received
May 7, 2019
Case Assigned To Post Registration Paralegal
May 9, 2019
Registered - Sec. 71 Accepted & Sec. 15 Ack.
May 9, 2019
Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed
May 21, 2020
New Representative At Ib Received
Jan 20, 2022
International Registration Renewed
Jul 16, 2022
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Nov 18, 2022
New Representative At Ib Received
Jul 14, 2023
Teas Section 71 Received
Jul 18, 2023
Change Of Name/Address Rec'd From Ib
Sep 16, 2023
Correction Transaction Received From Ib
Mar 25, 2024
Case Assigned To Post Registration Paralegal
May 11, 2024
Registered-Sec.71 Accepted
May 11, 2024
Notice Of Acceptance Of Sec. 71 - E-Mailed
Nov 6, 2023
Correction From Ib Entered - No Review Required
Trademark Alertz updated from USPTO on 2030-01-24
